In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 21st, 2008 | 31 | Yes |
Popular Name: 6-methoxy-N-(3-methoxyphenyl)-7-(3-morpholinopropoxy)quinazolin-4-amine 6-methoxy-N-(3-methoxyphenyl)-7-…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.46 | 7.57 | -14.94 | 1 | 8 | 0 | 78 | 424.501 | 9 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 37 | 0.34 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1110 | 0.27 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 1), Eukaryotic | Eukaryotes | 690 | 0.28 | Functional ≤ 10μM |
Z80005-1-O | 3T3 (Fibroblast Cells) (cluster #1 Of 2), Other | Other | 690 | 0.28 | Functional ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 1050 | 0.27 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 37 | 0.34 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 37 | 0.34 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1110 | 0.27 | Binding ≤ 10μM |
Z80005 | Z80005 | 3T3 (Fibroblast Cells) | 690 | 0.28 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 1050 | 0.27 | Functional ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 690 | 0.28 | Functional ≤ 10μM |
Description | Species |
---|---|
EPHA-mediated growth cone collapse | |
Integrin cell surface interactions | |
Neurophilin interactions with VEGF and VEGFR | |
Signaling by ERBB2 | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |